Frequent antiviral treatment failures in patients infected with hepatitis C virus genotype 4, subtype 4r.

Slim FOURATI, Christophe RODRIGUEZ, Christophe HEZODE, Alexandre SOULIER, Isaac RUIZ, Lila POITEAU, Stephane CHEVALIEZ, Jean-Michel PAWLOTSKY,

Hepatology 19/08/2018;- : - 10.1002/hep.30225

[Pemphigus and herpes: Multicentre survey and literature review].

M Merlant, V Seta, P Bernard, Slim FOURATI, JF Meritet, P Wolkenstein, N Dupin, P Joly, O Chosidow, S Ingen-Housz-Oro,

Ann Dermatol Venereol. 01/08/2018;145(8-9) : 477-485 10.1016/j.annder.2018.03.169. 14/06/2018

Characterization of the anti-hepatitis C virus activity of new non-peptidic small-molecule cyclophilin inhibitors with a potential for broad anti-Flaviviridae activity.

Quentin NEVERS, Isaac RUIZ, Nazim AHNOU, F Donati, Rozenn BRILLET, Laurent SOFTIC, M Chazal, N Jouvenet, Slim FOURATI, Camille BAUDESSON, Patrice BRUSCELLA, M Gelin, JF Guichou, Jean-Michel PAWLOTSKY, Abdelhakim AHMED-BELKACEM,

Antimicrob Agents Chemother. 14/05/2018;AAC : 00126-18 10.1128/AAC.00126-18

Approaches for simplified HCV diagnostic algorithms

Slim FOURATI, JJ Feld, Stephane CHEVALIEZ, N Luhmann,

J Int AIDS Soc. 01/04/2018;21 Suppl 2 : e25058 10.1002/jia2.25058.

Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor

Slim FOURATI, J Guedj, Stephane CHEVALIEZ, THT Nguyen, F Roudot-Thoraval, Isaac RUIZ, Alexandre SOULIER, G Scoazec, A Varaut, Lila POITEAU, Murielle FRANCOIS, A Mallat, Christophe HEZODE, Jean-Michel PAWLOTSKY,

Aliment Pharmacol Ther. 01/03/2018;47(5) : 665-673 10.1111/apt.14478. 22/12/2017

Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.

Slim FOURATI, Jean-Michel PAWLOTSKY,

Aliment Pharmacol Ther. 01/03/2018;47(6) : 849-850 10.1111/apt.14520.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Slim FOURATI, Dominique CHALLINE, JD Poveda, S Laperche, Sandrine RALLIER, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

J Clin Virol. 01/07/2017;92 : 69-74 10.1016/j.jcv.2017.05.015. 17/05/2017

Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.

Christophe HEZODE, Slim FOURATI, Stephane CHEVALIEZ, G Scoazec, Alexandre SOULIER, A Varaut, M Francois, Isaac RUIZ, F Roudot-Thoraval, A Mallat, Jean-Michel PAWLOTSKY,

Clin Infect Dis. 01/06/2017;64(11) : 1615-1618 10.1093/cid/cix214. 24/07/2017

Recent advances in understanding and diagnosing hepatitis B virus infection.

Slim FOURATI, Jean-Michel PAWLOTSKY,

F1000Res. 06/09/2016;5 : REV-2243 10.12688/f1000research.8983.1

Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

M Salmona, Slim FOURATI, L Feghoul, C Scieux, A Thiriez, F Simon, M Resche-Rigon, J LeGoff,

Diagn Microbiol Infect Dis. 01/08/2016;85(4) : 428-32 10.1016/j.diagmicrobio.2016.04.017. 28/04/2016